Nitric oxide and coronary vascular endothelium adaptations in hypertension

Vascular Health and Risk Management

Volumn 5, Issue , 2009, Pages 1075-1087

  Levy, Andrew S ^a   Chung, Justin C S ^a   Kroetsch, Jeffrey T ^a   Rush, James W E ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

Author keywords

Artery; eNOS; Estrogen; Oxidative stress; Polymorphism; Sex effect

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ADAPTATION; ANTIOXIDANT ACTIVITY; ARTERY ENDOTHELIUM; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; CORONARY VASCULAR RESISTANCE; DNA POLYMORPHISM; GENETIC HETEROGENEITY; HEART HEMODYNAMICS; HEREDITY; HUMAN; HYPERTENSION; MENOPAUSE; NONHUMAN; REVIEW; SEX DIFFERENCE; VASOMOTOR REFLEX;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CORONARY CIRCULATION; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; ESTROGENS; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION; MALE; MICE; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; SEX FACTORS;

EID: 74049128308     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: None     Document Type: Review

References (140)

1. Feigl EO. Coronary physiology. Physiol Rev. 1983;63:1-205.
2. Muller JM, Davis MJ, Chilian WM. Integrated regulation of pressure and flow in the coronary microcirculation. Cardiovasc Res. 1996;32:668-678.
3. Tune JD, Gorman MW, Feigl EO. Matching coronary blood flow to myocardial oxygen consumption. J Appl Physiol. 2004;97:404-415.
4. Westerhof N, Boer C, Lamberts RR, Sipkema P. Cross-talk between cardiac muscle and coronary vasculature. Physiol Rev. 2006;86:1263-1308.
5. Jones CJ, Kuo L, Davis MJ, Chilian WM. Regulation of coronary blood flow: coordination of heterogeneous control mechanisms in vascular microdomains. Cardiovasc Res. 1995;29:585-596.
6. Feliciano L, Henning RJ. Coronary artery blood flow: physiologic and pathophysiologic regulation. Clin Cardiol. 1999;22:775-786.
7. Chilian WM, Eastham CL, Marcus ML. Microvascular distribution of coronary vascular resistance in beating left ventricle. Am J Physiol. 1986;251:H779-H788.
8. Chilian WM. Microvascular pressures and resistances in the left ventricular subepicardium and subendocardium. Circ Res. 1991;69:561-570.
9. Nitenberg A, Antony I. Epicardial coronary arteries are not adequately sized in hypertensive patients. J Am Coll Cardiol. 1996;27:115-123.
10. Antony I, Nitenberg A. Coronary vascular reserve is similarly reduced in hypertensive patients without any other coronary risk factors and in normotensive smokers and hypercholesterolemic patients with angiographically normal coronary arteries. Am J Hypertens. 1997;10:181-188.
11. Kozakova M, Galetta F, Gregorini L, et al. Coronary vasodilator capacity and epicardial vessel remodeling in physiological and hypertensive hypertrophy. Hypertension. 2000;36:343-349.
12. Palombo C, Kozakova M, Magagna A, et al. Early impairment of coronary flow reserve and increase in minimum coronary resistance in borderline hypertensive patients. J Hypertens. 2000;18:453-459.
13. Wangler RD, Peters KG, Marcus ML, Tomanek RJ. Effects of duration and severity of arterial hypertension and cardiac hypertrophy on coronary vasodilator reserve. Circ Res. 1982;51:10-18.
14. Edoute Y, Luscher TF, Rubanyi GM. Autoregulation and vascular reserve in the coronary circulation of the spontaneously hypertensive rat. J Hypertens Suppl. 1986;4:S290-S292.
15. Friberg P, Wahlander H, Nordlander M. Structural and functional adaptations within the myocardium and coronary vessels after antihypertensive therapy in spontaneously hypertensive rats. J Hypertens Suppl. 1986;4:S519-S521.
16. Isoyama S, Sato F, Takishima T. Effect of age on coronary circulation after imposition of pressure-overload in rats. Hypertension. 1991;17:369-377.
17. Fujita H, Takeda K, Nakamura K, et al. Role of nitric oxide in impaired coronary circulation and improvement by angiotensin II receptor antagonist in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol Suppl. 1995;22:S148-S150.
18. Kelm M, Feelisch M, Krebber T, Deussen A, Motz W, Strauer BE. Role of nitric oxide in the regulation of coronary vascular tone in hearts from hypertensive rats. Maintenance of nitric oxide-forming capacity and increased basal production of nitric oxide. Hypertension. 1995;25:186-193.
19. Crabos M, Coste P, Paccalin M, et al. Reduced basal NO-mediated dilation and decreased endothelial NO-synthase expression in coronary vessels of spontaneously hypertensive rats. J Mol Cell Cardiol. 1997;29:55-65.
20. Susic D, Nunez E, Hosoya K, Frohlich ED. Coronary hemodynamics in aging spontaneously hypertensive and normotensive Wistar-Kyoto rats. J Hypertens. 1998;16:231-237.
21. Millette E, de CJ, Lamontagne D. Altered coronary dilation in deoxycorticosterone acetate-salt hypertension. J Hypertens. 2000;18: 1783-1793.
22. Mokuno S, Ito T, Numaguchi Y, et al. Impaired nitric oxide production and enhanced autoregulation of coronary circulation in young spontaneously hypertensive rats at prehypertensive stage. Hypertens Res. 2001;24:395-401.
23. Trippodo NC, Frohlich ED. Similarities of genetic (spontaneous) hypertension. Man and rat. Circ Res. 1981;48:309-319.
24. Bohr DF, Dominiczak AF. Experimental hypertension. Hypertension. 1991;17:I39-I44.
25. Yamori Y. Overview: studies on spontaneous hypertension-development from animal models toward man. Clin Exp Hypertens A. 1991;13:631-644.
26. Pinto YM, Paul M, Ganten D. Lessons from rat models of hypertension: from Goldblatt to genetic engineering. Cardiovasc Res. 1998;39:77-88.
27. Yagil Y, Yagil C. Genetic models of hypertension in experimental animals. Exp Nephrol. 2001;9:1-9.
28. Lerman LO, Chade AR, Sica V, Napoli C. Animal models of hypertension: an overview. J Lab Clin Med. 2005;146:160-173.
29. Hutchins PM, Lynch CD, Cooney PT, Curseen KA. The microcirculation in experimental hypertension and aging. Cardiovasc Res. 1996;32:772-780.
30. Greene AS. Microvascular regulation and dysregulation. In: Izzo JL Jr, Black HR, editors. Hypertension Primer: The essentials of high blood pressure. 3rd ed. Philidelphia, PA: Lippincott Williams & Wilkins; 2003. p. 183-185.
31. Garcia SR, Izzard AS, Heagerty AM, Bund SJ. Myogenic tone in coronary arteries from spontaneously hypertensive rats. J Vasc Res. 1997;34:109-116.
32. Ghaleh B, Hittinger L, Kim SJ, et al. Selective large coronary endothelial dysfunction in conscious dogs with chronic coronary pressure overload. Am J Physiol. 1998;274:H539-H551.
33. Bund SJ. Influence of mode of contraction on the mechanism of acetylcholine-mediated relaxation of coronary arteries from normotensive and spontaneously hypertensive rats. Clin Sci (Lond). 1998;94:231-238.
34. Baumbach GL, Heistad DD. Remodeling of cerebral arterioles in chronic hypertension. Hypertension. 1989;13:968-972.
35. Baumbach GL. Mechanisms of vascular remodeling. In: Izzo JL Jr, Black HR, editors. Hypertension Primer: The essentials of high blood pressure. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2003. p. 180-183.
36. Millette E, Demeilliers B, Wu R, et al. Comparison of the cardiovascular protection by omapatrilat and lisinopril treatments in DOCA-salt hypertension. J Hypertens. 2003;21:125-135.
37. Vanhoutte PM, Feletou M, Taddei S. Endothelium-dependent contractions in hypertension. Br J Pharmacol. 2005;144:449-458.
38. Feletou M, Vanhoutte PM. Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol. 2006;291:H985-H1002.
39. Liu Y, Gutterman DD. Vascular control in humans: focus on the coronary microcirculation. Basic Res Cardiol. 2009;104:211-227.
40. Godecke A, Decking UK, Ding Z, et al. Coronary hemodynamics in endothelial NO synthase knockout mice. Circ Res. 1998;82:186-194.
41. + channels. Circulation. 1999;99: 3132-3138.
42. Godecke A, Schrader J. Adaptive mechanisms of the cardiovascular system in transgenic mice - lessons from eNOS and myoglobin knockout mice. Basic Res Cardiol. 2000;95:492-498.
43. + channels. Circulation. 2001;103:1992-1998.
44. Ding Z, Godecke A, Schrader J. Contribution of cytochrome P450 metabolites to bradykinin-induced vasodilation in endothelial NO synthase deficient mouse hearts. Br J Pharmacol. 2002;135:631-638.
45. Aubin MC, Gendron ME, Lebel V, et al. Alterations in the endothelial G-protein coupled receptor pathway in epicardial arteries and subendocardial arterioles in compensated left ventricular hypertrophy. Basic Res Cardiol. 2007;102:144-153.
46. Heintz A, Damm M, Brand M, Koch T, Deussen A. Coronary flow regulation in mouse heart during hypercapnic acidosis: role of NO and its compensation during eNOS impairment. Cardiovasc Res. 2008;77:188-196.
47. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87:840-844.
48. Rush JW, Denniss SG, Graham DA. Vascular nitric oxide and oxidative stress: determinants of endothelial adaptations to cardiovascular disease and to physical activity. Can J Appl Physiol. 2005;30:442-474.
49. Kelm M, Schrader J. Control of coronary vascular tone by nitric oxide. Circ Res. 1990;66:1561-1575.
50. Tschudi MR, Noll G, Arnet U, Novosel D, Ganten D, Luscher TF. Alterations in coronary artery vascular reactivity of hypertensive Ren-2 transgenic rats. Circulation. 1994;89:2780-2786.
51. Bouloumie A, Bauersachs J, Linz W, et al. Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production. Hypertension. 1997;30:934-941.
52. Bauersachs J, Bouloumie A, Mulsch A, Wiemer G, Fleming I, Busse R. Vasodilator dysfunction in aged spontaneously hypertensive rats: changes in NO synthase III and soluble guanylyl cyclase expression, and in superoxide anion production. Cardiovasc Res. 1998;37:772-779.
53. Brush JE Jr, Faxon DP, Salmon S, Jacobs AK, Ryan TJ. Abnormal endothelium-dependent coronary vasomotion in hypertensive patients. J Am Coll Cardiol. 1992;19:809-815.
54. Treasure CB, Manoukian SV, Klein JL, et al. Epicardial coronary artery responses to acetylcholine are impaired in hypertensive patients. Circ Res. 1992;71:776-781.
55. Treasure CB, Klein JL, Vita JA, et al. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation. 1993;87:86-93.
56. Quyyumi AA, Dakak N, Andrews NP, et al. Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. J Clin Invest. 1995;95:1747-1755.
57. Houghton JL, Davison CA, Kuhner PA, Torossov MT, Strogatz DS, Carr AA. Heterogeneous vasomotor responses of coronary conduit and resistance vessels in hypertension. J Am Coll Cardiol. 1998;31: 374-382.
58. Pourageaud F, Freslon JL. Endothelial and smooth muscle properties of coronary and mesenteric resistance arteries in spontaneously hypertensive rats compared to WKY rats. Fundam Clin Pharmacol. 1995;9:37-45.
59. Pourageaud F, Freslon JL. Impaired endothelial relaxations induced by agonists and flow in spontaneously hypertensive rat compared to Wistar-Kyoto rat perfused coronary arteries. J Vasc Res. 1995;32: 190-199.
60. MacCarthy PA, Shah AM. Impaired endothelium-dependent regulation of ventricular relaxation in pressure-overload cardiac hypertrophy. Circulation. 2000;101:1854-1860.
61. Malo O, Carrier M, Shi YF, Tardif JC, Tanguay JF, Perrault LP. Specific alterations of endothelial signal transduction pathways of porcine epicardial coronary arteries in left ventricular hypertrophy. J Cardiovasc Pharmacol. 2003;42:275-286.
62. Demirci B, McKeown PP, Bayraktutan U. Blockade of angiotensin II provides additional benefits in hypertension- and ageing-related cardiac and vascular dysfunctions beyond its blood pressure-lowering effects. J Hypertens. 2005;23:2219-2227.
63. Tschudi MR, Criscione L, Luscher TF. Effect of aging and hypertension on endothelial function of rat coronary arteries. J Hypertens Suppl. 1991;9:S164-S165.
64. Gauthier-Rein KM, Rusch NJ. Distinct endothelial impairment in coronary microvessels from hypertensive Dahl rats. Hypertension. 1998;31:328-334.
65. Fuchs LC, Nuno D, Lamping KG, Johnson AK. Characterization of endothelium-dependent vasodilation and vasoconstriction in coronary arteries from spontaneously hypertensive rats. Am J Hypertens. 1996;9:475-483.
66. Kelm M, Feelisch M, Krebber T, Motz W, Strauer BE. The role of nitric oxide in the regulation of coronary vascular resistance in arterial hypertension: comparison of normotensive and spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1992;20 Suppl 12:S183-S186.
67. Duffy SJ, Castle SF, Harper RW, Meredith IT. Contribution of vasodilator prostanoids and nitric oxide to resting flow, metabolic vasodilation, and flow-mediated dilation in human coronary circulation. Circulation. 1999;100:1951-1957.
68. Tschudi MR, Criscione L, Novosel D, Pfeiffer K, Luscher TF. Antihypertensive therapy augments endothelium-dependent relaxations in coronary arteries of spontaneously hypertensive rats. Circulation. 1994;89:2212-2218.
69. Vazquez-Perez S, Navarro-Cid J, de las HN, et al. Relevance of endothelium-derived hyperpolarizing factor in the effects of hypertension on rat coronary relaxations. J Hypertens. 2001;19:539-545.
70. Garcia SR, Bund SJ. Nitric oxide modulation of coronary artery myogenic tone in spontaneously hypertensive and Wistar-Kyoto rats. Clin Sci (Lond). 1998;94:225-229.
71. Zhang C, Hein TW, Wang W, et al. Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles. Hypertension. 2004;44:935-943.
72. Rush JW, Ford RJ. Nitric oxide, oxidative stress and vascular endothelium in health and hypertension. Clin Hemorheol Microcirc. 2007;37: 185-192.
73. Rodriguez-Porcel M, Lerman LO, Herrmann J, Sawamura T, Napoli C, Lerman A. Hypercholesterolemia and hypertension have synergistic deleterious effects on coronary endothelial function. Arterioscler Thromb Vasc Biol. 2003;23:885-891.
74. Zhu XY, Daghini E, Chade AR, et al. Role of oxidative stress in remodeling of the myocardial microcirculation in hypertension. Arterioscler Thromb Vasc Biol. 2006;26:1746-1752.
75. Lu Z, Xu X, Hu X, et al. Extracellular superoxide dismutase deficiency exacerbates pressure overload-induced left ventricular hypertrophy and dysfunction. Hypertension. 2008;51:19-25.
76. Lee MY, Griendling KK. Redox signaling, vascular function, and hypertension. Antioxid Redox Signal. 2008;10:1045-1059.
77. Munzel T, Daiber A, Ullrich V, Mulsch A. Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler Thromb Vasc Biol. 2005;25:1551-1557.
78. Thomas SR, Witting PK, Drummond GR. Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal. 2008;10:1713-1765.
79. Huang PL, Huang Z, Mashimo H, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 1995;377:239-242.
80. Kubis N, Besnard S, Silvestre JS, et al. Decreased arteriolar density in endothelial nitric oxide synthase knockout mice is due to hypertension, not to the constitutive defect in endothelial nitric oxide synthase enzyme. J Hypertens. 2002;20:273-280.
81. -/-). J Hypertens. 2002;20:1581-1587.
82. Chataigneau T, Feletou M, Huang PL, Fishman MC, Duhault J, Vanhoutte PM. Acetylcholine-induced relaxation in blood vessels from endothelial nitric oxide synthase knockout mice. Br J Pharmacol. 1999;126:219-226.
83. Lamping KG, Nuno DW, Shesely EG, Maeda N, Faraci FM. Vasodilator mechanisms in the coronary circulation of endothelial nitric oxide synthase-deficient mice. Am J Physiol Heart Circ Physiol. 2000;279: H1906-H1912.
84. Michel T, Feron O. Nitric oxide synthases: which, where, how, and why? J Clin Invest. 1997;100:2146-2152.
85. Nava E, Noll G, Luscher TF. Increased activity of constitutive nitric oxide synthase in cardiac endothelium in spontaneous hypertension. Circulation. 1995;91:2310-2313.
86. Piech A, Massart PE, Dessy C, et al. Decreased expression of myocardial eNOS and caveolin in dogs with hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol. 2002;282:H219-H231.
87. Ravalli S, Albala A, Ming M, et al. Inducible nitric oxide synthase expression in smooth muscle cells and macrophages of human transplant coronary artery disease. Circulation. 1998;97:2338-2345.
88. Vaziri ND, Ni Z, Oveisi F, Trnavsky-Hobbs DL. Effect of antioxidant therapy on blood pressure and NO synthase expression in hypertensive rats. Hypertension. 2000;36:957-964.
89. Huang A, Sun D, Shesely EG, Levee EM, Koller A, Kaley G. Neuronal NOS-dependent dilation to flow in coronary arteries of male eNOS-KO mice. Am J Physiol Heart Circ Physiol. 2002;282:H429-H436.
90. Ungvari Z, Csiszar A, Edwards JG, et al. Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factor-alpha, NAD(P)H oxidase, and inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol. 2003;23:418-424.
91. Graham DA, Rush JW. Exercise training improves aortic endothelium-dependent vasorelaxation and determinants of nitric oxide bioavailability in spontaneously hypertensive rats. J Appl Physiol. 2004;96:2088-2096.
92. Li H, Witte K, August M, et al. Reversal of endothelial nitric oxide synthase uncoupling and up-regulation of endothelial nitric oxide synthase expression lowers blood pressure in hypertensive rats. J Am Coll Cardiol. 2006;47:2536-2544.
93. Schulz E, Jansen T, Wenzel P, Daiber A, Munzel T. Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal. 2008;10:1115-1126.
94. Malo O, Desjardins F, Tanguay JF, Tardif JC, Carrier M, Perrault LP. Tetrahydrobiopterin and antioxidants reverse the coronary endothelial dysfunction associated with left ventricular hypertrophy in a porcine model. Cardiovasc Res. 2003;59:501-511.
95. Khadour FH, Kao RH, Park S, Armstrong PW, Holycross BJ, Schulz R. Age-dependent augmentation of cardiac endothelial NOS in a genetic rat model of heart failure. Am J Physiol. 1997;273:H1223-H1230.
96. Miyamoto Y, Saito Y, Kajiyama N, et al. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension. 1998;32:3-8.
97. Wang XL, Wang J. Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol Genet Metab. 2000;70:241-251.
98. Sandrim VC, de Syllos RW, Lisboa HR, Tres GS, Tanus-Santos JE. Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus. Atherosclerosis. 2006;189:241-246.
99. Sandrim VC, de Syllos RW, Lisboa HR, Tres GS, Tanus-Santos JE. Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients. Nitric Oxide. 2007;16:348-355.
100. Nakayama M, Yasue H, Yoshimura M, et al. T-786 - >C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation. 1999;99:2864-2870.
101. Wang J, Dudley D, Wang XL. Haplotype-specific effects on endothelial NO synthase promoter efficiency: modifiable by cigarette smoking. Arterioscler Thromb Vasc Biol. 2002;22:e1-e4.
102. Naber CK, Baumgart D, Altmann C, Siffert W, Erbel R, Heusch G. eNOS 894T allele and coronary blood flow at rest and during adenosine-induced hyperemia. Am J Physiol Heart Circ Physiol. 2001;281:H1908-H1912.
103. Kunnas TA, Lehtimaki T, Laaksonen R, et al. Endothelial nitric oxide synthase genotype modulates the improvement of coronary blood flow by pravastatin: a placebo-controlled PET study. J Mol Med. 2002;80:802-807.
104. Laughlin MH, Turk JR, Schrage WG, Woodman CR, Price EM. Influence of coronary artery diameter on eNOS protein content. Am J Physiol Heart Circ Physiol. 2003;284:H1307-H1312.
105. Qiu Y, Tarbell JM. Numerical simulation of pulsatile flow in a compliant curved tube model of a coronary artery. J Biomech Eng. 2000;122:77-85.
106. Dancu MB, Berardi DE, Vanden Heuvel JP, Tarbell JM. Asynchronous shear stress and circumferential strain reduces endothelial NO synthase and cyclooxygenase-2 but induces endothelin-1 gene expression in endothelial cells. Arterioscler Thromb Vasc Biol. 2004;24:2088-2094.
107. Dancu MB, Tarbell JM. Coronary endothelium expresses a pathologic gene pattern compared to aortic endothelium: correlation of asynchronous hemodynamics and pathology in vivo. Atherosclerosis. 2007;192:9-14.
108. Laughlin MH, Pollock JS, Amann JF, Hollis ML, Woodman CR, Price EM. Training induces nonuniform increases in eNOS content along the coronary arterial tree. J Appl Physiol. 2001;90:501-510.
109. Muller JM, Myers PR, Laughlin MH. Vasodilator responses of coronary resistance arteries of exercise-trained pigs. Circulation. 1994;89:2308-2314.
110. Nathan L, Chaudhuri G. Estrogens and atherosclerosis. Annu Rev Pharmacol Toxicol. 1997;37:477-515.
111. Barber DA, Miller VM. Gender differences in endothelium-dependent relaxations do not involve NO in porcine coronary arteries. Am J Physiol. 1997;273:H2325-H2332.
112. 2+ and ecNOS activity. Am J Physiol. 1999;276:H961-H969.
113. + channels. Circ Res. 1996;79:1024-1030.
114. Darkow DJ, Lu L, White RE. Estrogen relaxation of coronary artery smooth muscle is mediated by nitric oxide and cGMP. Am J Physiol. 1997;272:H2765-H2773.
115. Ma L, Robinson CP, Thadani U, Patterson E. Effect of 17-beta estradiol in the rabbit: endothelium-dependent and -independent mechanisms of vascular relaxation. J Cardiovasc Pharmacol. 1997;30:130-135.
116. Kauser K, Rubanyi GM. Gender difference in endothelial dysfunction in the aorta of spontaneously hypertensive rats. Hypertension. 1995;25:517-523.
117. Graham DA, Rush JWE. Cyclooxygenase and thromboxane/ prostaglandin receptor contribute to aortic endothelium-dependent dysfunction in aging female spontaneously hypertensive rats. J Appl Physiol. 2009;107:1059-1067.
118. McIntyre M, Hamilton CA, Rees DD, Reid JL, Dominiczak AF. Sex differences in the abundance of endothelial nitric oxide in a model of genetic hypertension. Hypertension. 1997;30:1517-1524.
119. Pinto S, Virdis A, Ghiadoni L, et al. Endogenous estrogen and acetylcholine-induced vasodilation in normotensive women. Hypertension. 1997;29:268-273.
120. Lima SM, Aldrighi JM, Consolim-Colombo FM, et al. Acute administration of 17beta-estradiol improves endothelium-dependent vasodilation in postmenopausal women. Maturitas. 2005;50:266-274.
121. New G, Duffy SJ, Harper RW, Meredith IT. Estrogen improves acetylcholine-induced but not metabolic vasodilation in biological males. Am J Physiol. 1999;277:H2341-H2347.
122. Collins P, Shay J, Jiang C, Moss J. Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation after acute estrogen withdrawal. Circulation. 1994;90:1964-1968.
123. Gorodeski GI, Yang T, Levy MN, Goldfarb J, Utian WH. Effects of estrogen in vivo on coronary vascular resistance in perfused rabbit hearts. Am J Physiol. 1995;269:R1333-R1338.
124. Lang U, Baker RS, Clark KE. Estrogen-induced increases in coronary blood flow are antagonized by inhibitors of nitric oxide synthesis. Eur J Obstet Gynecol Reprod Biol. 1997;74:229-235.
125. + channels in coronary vasodilation induced by 17beta-estradiol in ischemic heart failure. FASEB J. 1997;11:793-799.
126. Bell DR, Rensberger HJ, Koritnik DR, Koshy A. Estrogen pretreatment directly potentiates endothelium-dependent vasorelaxation of porcine coronary arteries. Am J Physiol. 1995;268:H377-H383.
127. Hayashi T, Yamada K, Esaki T, et al. Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun. 1995;214:847-855.
128. Hishikawa K, Nakaki T, Marumo T, Suzuki H, Kato R, Saruta T. Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett. 1995;360:291-293.
129. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest. 1999; 103:401-406.
130. Huang A, Sun D, Koller A, Kaley G. Gender difference in myogenic tone of rat arterioles is due to estrogen-induced, enhanced release of NO. Am J Physiol. 1997;272:H1804-H1809.
131. Thompson LP, Weiner CP. Long-term estradiol replacement decreases contractility of guinea pig coronary arteries to the thromboxane mimetic U46619. Circulation. 1997;95:709-714.
132. Kleinert H, Wallerath T, Euchenhofer C, Ihrig-Biedert I, Li H, Forstermann U. Estrogens increase transcription of the human endothelial NO synthase gene: analysis of the transcription factors involved. Hypertension. 1998;31:582-588.
133. Siow RC, Li FY, Rowlands DJ, de WP, Mann GE. Cardiovascular targets for estrogens and phytoestrogens: transcriptional regulation of nitric oxide synthase and antioxidant defense genes. Free Radic Biol Med. 2007;42:909-925.
134. Muller-Delp JM, Lubahn DB, Nichol KE, et al. Regulation of nitric oxide-dependent vasodilation in coronary arteries of estrogen receptor-alpha-deficient mice. Am J Physiol Heart Circ Physiol. 2003;285:H2150-H2157.
135. Yang S, Bae L, Zhang L. Estrogen increases eNOS and NOx release in human coronary artery endothelium. J Cardiovasc Pharmacol. 2000;36:242-247.
136. Gilligan DM, Quyyumi AA, Cannon RO III. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation. 1994;89:2545-2551.
137. Russell KS, Haynes MP, Caulin-Glaser T, Rosneck J, Sessa WC, Bender JR. Estrogen stimulates heat shock protein 90 binding to endothelial nitric oxide synthase in human vascular endothelial cells. Effects on calcium sensitivity and NO release. J Biol Chem. 2000;275: 5026-5030.
138. 2+-calmodulin and caveolin. J Biol Chem. 1997;272:15583-15586.
139. Gragasin FS, Xu Y, Arenas IA, Kainth N, Davidge ST. Estrogen reduces angiotensin II-induced nitric oxide synthase and NAD(P)H oxidase expression in endothelial cells. Arterioscler Thromb Vasc Biol. 2003;23:38-44.
140. Romer W, Oettel M, Droescher P, Schwarz S. Novel " scavestrogens" and their radical scavenging effects, iron-chelating, and total antioxidative activities: delta 8,9-dehydro derivatives of 17 alpha-estradiol and 17 beta-estradiol. Steroids. 1997;62:304-310.